Notice of Results

Clinigen Group plc

Notification of Full Year Results Date

Burton-on-Trent, UK - 04 September 2014 - Clinigen Group plc (AIM: CLIN), the global specialty pharmaceuticals and services company, will announce its full year results for the year ended 30 June 2014 on Wednesday, 24 September 2014.

A group analyst briefing will be held at 09:30am BST on Wednesday, 24 September 2014 at Instinctif Partners' offices at 65 Gresham Street, London EC2V 7NQ.

- Ends -

About Clinigen Group

The Clinigen Group is a specialty global pharmaceutical company headquartered in the UK, with offices in the US and Japan. The Group, dedicated to delivering 'the right drug, to the right patient at the right time', has three operating businesses; Specialty Pharmaceuticals (SP), Clinical Trials Supply (CTS), and Global Access Programs (GAP). SP focuses on acquiring and in licensing specialist, hospital only medicines worldwide and commercializing them within niche markets. CTS sources commercial medical products for use in clinical studies only, including comparator drugs, adjuvant drugs and rescue therapies. GAP specializes in the consultancy, development, management and implementation of programs providing access for patients and their clinicians to drugs not available in their markets.

For more information, please visit www.clinigengroup.com.

Contact Details